A biopsy report is a pathologist’s microscopic diagnosis of tissue removed by needle, endoscopy or surgery. The most important line is usually the final diagnosis, but cancer reports may also include tumour type, grade, depth of invasion, margin status and special tests. Grade describes how aggressive the cells look; stage describes how far the cancer has grown or spread, so the two are not the same. A biopsy sample may not contain enough tissue to determine the final surgical stage. Read the report with your urologist rather than interpreting one word in isolation, because the next step depends on the pathology together with imaging, blood tests and the procedure that produced the sample.

Four questions turn a pathology report into a treatment discussion

1. What is it? The exact tumour or tissue diagnosis.
2. How aggressive does it look? Grade, Gleason/ISUP group or other disease-specific grading.
3. How far has it gone in the tissue examined? Invasion, muscle involvement, stage information or other local extent.
4. Was the relevant tissue completely removed? Margins matter after some operations, but not every biopsy is intended to remove the whole lesion.

A pathology report is therefore not a single “positive/negative” result. The next decision comes from combining these details with imaging, examination and the operation that produced the specimen.

What is a pathology report?

A pathology report describes tissue examined by a pathologist, a doctor trained to diagnose disease by studying cells and tissues. The report typically records where the specimen came from, how it was obtained, what it looked like macroscopically and microscopically, and the final diagnosis.

In many cancers, pathology provides the definitive diagnosis.

Start with the specimen label

Before interpreting the result, check which organ and sample the report refers to. A patient may have multiple containers labelled, for example, “right prostate base,” “bladder tumour,” “deep muscle,” “left renal mass” or “urethral biopsy.”

Different samples from the same operation can show different findings.

Benign, atypical, suspicious and malignant

Benign

No cancer is identified in the examined tissue. A benign result can still show inflammation, hyperplasia or another non-cancer condition.

Atypical/suspicious

Cells are abnormal but the pathologist may not have enough evidence to make a definite cancer diagnosis. Additional tissue, special stains or repeat biopsy may be needed.

Malignant

Cancer is identified. The report should usually specify the tumour type.

The wording and implications differ by organ, so a “negative” biopsy does not always end evaluation if imaging or clinical suspicion remains high.

What does tumour type mean?

Type tells you what kind of cancer it is based on the cells of origin. Common urological examples include:

• Prostate adenocarcinoma.
• Urothelial carcinoma of the bladder/upper urinary tract.
• Renal cell carcinoma.
• Germ-cell tumours of the testis.
• Squamous cell carcinoma in selected sites.

Treatment pathways differ substantially between these cancers.

What does grade mean?

Grade describes how abnormal the tumour cells look and is used as a marker of biological aggressiveness. Higher grade generally indicates a greater tendency to grow or spread, but grading systems differ by cancer.

Do not compare a “grade 2” kidney tumour with a “grade 2” cancer in another organ as if the numbers mean the same thing.

Prostate biopsy: Gleason score and ISUP Grade Group

Prostate cancer is commonly graded using Gleason patterns and ISUP Grade Groups. The Gleason score combines the two most relevant growth patterns, such as 3+4=7 or 4+3=7. These are not equivalent: 4+3 generally represents a less favourable pattern than 3+4.

ISUP Grade Groups range from 1 to 5 and simplify risk communication. Your urologist also considers PSA, MRI findings, clinical stage and how many biopsy cores contain cancer.

Bladder biopsy: low grade vs high grade and muscle invasion

Bladder pathology often focuses on whether the tumour is low or high grade and whether it invades the lamina propria or muscularis propria (detrusor muscle). A TURBT specimen may include separate superficial tumour and deep muscle samples.

The presence or absence of muscle in the specimen can be important when deciding whether staging is adequate.

Kidney tumour pathology

After partial or radical nephrectomy, the report may describe renal-cell carcinoma subtype, tumour size, grade, extension beyond the kidney, vascular invasion and surgical margins. These features contribute to pathological stage and follow-up planning.

What are surgical margins?

A margin is the edge of tissue removed during surgery. A negative/clear margin means no tumour is seen at the cut edge. A positive/involved margin means tumour cells reach the edge.

A positive margin does not automatically mean visible cancer remains or that another operation is always required; its significance depends on the organ, tumour type and overall context.

What does “invasion” mean?

Invasion describes cancer growing into surrounding tissue layers. Terms such as lamina propria invasion, muscle invasion, perineural invasion, lymphovascular invasion or capsular/extracapsular extension have different significance depending on the cancer.

Ask which findings change stage or treatment rather than trying to rank every microscopic phrase yourself.

Stage vs grade

Grade = how abnormal/aggressive the cells look under the microscope.

Stage = how far the tumour has grown within the organ and whether it has spread to lymph nodes or distant sites.

A biopsy can establish cancer and grade but may not provide complete stage. Imaging and definitive surgery can add staging information.

What are immunohistochemistry and molecular tests?

Special stains can help confirm what type of tumour is present. Molecular or biomarker tests may be ordered in selected cancers to refine diagnosis, inherited-risk assessment or treatment decisions. These results may appear in an addendum rather than the first report.

What does “pending” or “addendum to follow” mean?

The pathologist may be waiting for deeper sections, special stains, molecular tests or expert review. The first document may therefore not be the final report.

Questions to ask when reviewing a biopsy report

• What is the exact diagnosis?
• Is this definitely cancer?
• What is the grade?
• Can stage be determined from this sample?
• Are margins relevant in this specimen?
• Is muscle/deep tissue present when needed for bladder staging?
• Do I need additional imaging or repeat biopsy?
• Does the result change treatment urgency?
• Should the slides be reviewed by a specialist pathologist?

FAQs

Related reading

• Understanding Your Discharge Summary
• Follow-Up After Urology Surgery
• What to Ask Your Urologist Before Surgery
• Red Flags After Urology Surgery
• Urologist in Latur

References

• National Cancer Institute. Surgical Pathology Reports https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/pathology-reports-fact-sheet
• National Cancer Institute. Cancer Staging https://www.cancer.gov/about-cancer/diagnosis-staging/staging